deltatrials
Recruiting OBSERVATIONAL NCT04442334

The European NAFLD Registry

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Updated 9 times since 2020 Last updated: Jan 5, 2023 Started: May 1, 2015 Primary completion: Dec 31, 2030 Completion: Dec 31, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Cardiovascular Diseases and Dyslipidaemia and is currently actively recruiting participants. Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jul 2020 – ~Nov 2020 · 4 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotRecruiting~Dec 2021 – ~Jun 2022 · 6 months · monthly snapshotRecruiting~Jun 2022 – ~Feb 2023 · 8 months · monthly snapshotRecruiting~Feb 2023 – ~Jul 2024 · 17 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotRecruiting~Sep 2025 – present · 8 months · monthly snapshotRecruiting

Change History

9 versions recorded
  1. Sep 2025 — Present [monthly]

    Recruiting

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting

  4. Feb 2023 — Jul 2024 [monthly]

    Recruiting

  5. Jun 2022 — Feb 2023 [monthly]

    Recruiting

Show 4 earlier versions
  1. Dec 2021 — Jun 2022 [monthly]

    Recruiting

  2. Jan 2021 — Dec 2021 [monthly]

    Recruiting

  3. Nov 2020 — Jan 2021 [monthly]

    Recruiting

  4. Jul 2020 — Nov 2020 [monthly]

    Recruiting

    First recorded

May 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
  • Assistance Publique - Hôpitaux de Paris
  • Catholic University of the Sacred Heart
  • Institute of Cardiometabolism and Nutrition, France
  • Linkoeping University
  • Medical University of Vienna
  • National and Kapodistrian University of Athens
  • Newcastle University
  • Newcastle-upon-Tyne Hospitals NHS Trust
  • RWTH Aachen University
  • UMC Utrecht
  • University Hospital, Antwerp
  • University Medical Center Mainz
  • University of Angers
  • University of Bern
  • University of Birmingham
  • University of Cambridge
  • University of Florence
  • University of Helsinki
  • University of Lisbon
  • University of Milan
  • University of Nottingham
  • University of Oxford
  • University of Palermo
  • University of Turin, Italy
  • Wuerzburg University Hospital
  • Örebro University, Sweden
Data source: Newcastle University

For direct contact, visit the study record on ClinicalTrials.gov .